TY - JOUR
T1 - Preference for and impact of telehealth vs in-person asthma visits among Black and Latinx adults
AU - Ugalde, Israel C.
AU - Ratigan, Amanda
AU - Merriman, Conner
AU - Cui, Jing
AU - Ericson, Brianna
AU - Busse, Paula
AU - Carroll, Jennifer K.
AU - Casale, Thomas
AU - Celedón, Juan Carlos
AU - Coyne-Beasley, Tamera
AU - Fagan, Maureen
AU - Fuhlbrigge, Anne L.
AU - Villarreal, Gabriela Gaona
AU - Hernandez, Paulina Arias
AU - Jariwala, Sunit
AU - Kruse, Jean
AU - Maher, Nancy E.
AU - Manning, Brian
AU - Mosnaim, Giselle
AU - Nazario, Sylvette
AU - Pace, Wilson D.
AU - Phipatanakul, Wanda
AU - Pinto-Plata, Victor
AU - Riley, Isaretta
AU - Rodriguez-Louis, Jacqueline
AU - Salciccioli, Justin
AU - Shenoy, Kartik
AU - Shields, Joel B.
AU - Tarabichi, Yasir
AU - Sosa, Bonnie Telon
AU - Wechsler, Michael E.
AU - Wisnivesky, Juan
AU - Yawn, Barbara
AU - Israel, Elliot
AU - Cardet, Juan Carlos
N1 - Publisher Copyright:
© 2023 American College of Allergy, Asthma & Immunology
PY - 2023/11
Y1 - 2023/11
N2 - Background: Black and Latinx adults experience disproportionate asthma-related morbidity and limited specialty care access. The severe acute respiratory syndrome coronavirus 2 pandemic expanded telehealth use. Objective: To evaluate visit type (telehealth [TH] vs in-person [IP]) preferences and the impact of visit type on asthma outcomes among Black and Latinx adults with moderate-to-severe asthma. Methods: For this PREPARE trial ancillary study, visit type preference was surveyed by e-mail or telephone post-trial. Emergency medical record data on visit types and asthma outcomes were available for a subset (March 2020 to April 2021). Characteristics associated with visit type preferences, and relationships between visit type and asthma outcomes (control [Asthma Control Test] and asthma-related quality of life [Asthma Symptom Utility Index]), were tested using multivariable regression. Results: A total of 866 participants consented to be surveyed, with 847 respondents. Among the participants with asthma care experience with both visit types, 42.0% preferred TH for regular checkups, which associated with employment (odds ratio [OR] = 1.61; 95% confidence interval [CI], 1.09-2.39; P =.02), lower asthma medication adherence (OR = 1.06; 95% CI, 1.01-1.11; P =.03), and having more historical emergency department and urgent care asthma visits (OR = 1.10 for each additional visit; 95% CI, 1.02-1.18; P =.02), after adjustment. Emergency medical record data were available for 98 participants (62 TH, 36 IP). Those with TH visits were more likely Latinx, from the Southwest, employed, using inhaled corticosteroid–only controller therapy, with lower body mass index, and lower self-reported asthma medication adherence vs those with IP visits only. Both groups had comparable Asthma Control Test (18.4 vs 18.9, P =.52) and Asthma Symptom Utility Index (0.79 vs 0.84, P =.16) scores after adjustment. Conclusion: TH may be similarly efficacious as and often preferred over IP among Black and Latinx adults with moderate-to-severe asthma, especially for regular checkups. Trial Registration: ClinicalTrials.gov Identifier: NCT02995733.
AB - Background: Black and Latinx adults experience disproportionate asthma-related morbidity and limited specialty care access. The severe acute respiratory syndrome coronavirus 2 pandemic expanded telehealth use. Objective: To evaluate visit type (telehealth [TH] vs in-person [IP]) preferences and the impact of visit type on asthma outcomes among Black and Latinx adults with moderate-to-severe asthma. Methods: For this PREPARE trial ancillary study, visit type preference was surveyed by e-mail or telephone post-trial. Emergency medical record data on visit types and asthma outcomes were available for a subset (March 2020 to April 2021). Characteristics associated with visit type preferences, and relationships between visit type and asthma outcomes (control [Asthma Control Test] and asthma-related quality of life [Asthma Symptom Utility Index]), were tested using multivariable regression. Results: A total of 866 participants consented to be surveyed, with 847 respondents. Among the participants with asthma care experience with both visit types, 42.0% preferred TH for regular checkups, which associated with employment (odds ratio [OR] = 1.61; 95% confidence interval [CI], 1.09-2.39; P =.02), lower asthma medication adherence (OR = 1.06; 95% CI, 1.01-1.11; P =.03), and having more historical emergency department and urgent care asthma visits (OR = 1.10 for each additional visit; 95% CI, 1.02-1.18; P =.02), after adjustment. Emergency medical record data were available for 98 participants (62 TH, 36 IP). Those with TH visits were more likely Latinx, from the Southwest, employed, using inhaled corticosteroid–only controller therapy, with lower body mass index, and lower self-reported asthma medication adherence vs those with IP visits only. Both groups had comparable Asthma Control Test (18.4 vs 18.9, P =.52) and Asthma Symptom Utility Index (0.79 vs 0.84, P =.16) scores after adjustment. Conclusion: TH may be similarly efficacious as and often preferred over IP among Black and Latinx adults with moderate-to-severe asthma, especially for regular checkups. Trial Registration: ClinicalTrials.gov Identifier: NCT02995733.
UR - http://www.scopus.com/inward/record.url?scp=85167784331&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85167784331&partnerID=8YFLogxK
U2 - 10.1016/j.anai.2023.07.012
DO - 10.1016/j.anai.2023.07.012
M3 - Article
C2 - 37490981
AN - SCOPUS:85167784331
SN - 1081-1206
VL - 131
SP - 614-627.e2
JO - Annals of Allergy, Asthma and Immunology
JF - Annals of Allergy, Asthma and Immunology
IS - 5
ER -